Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C9H16N2O2 |
| Molecular Weight | 184.2355 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C(CC=C)C(=O)NC(N)=O
InChI
InChIKey=KSUUMAWCGDNLFK-UHFFFAOYSA-N
InChI=1S/C9H16N2O2/c1-4-5-7(6(2)3)8(12)11-9(10)13/h4,6-7H,1,5H2,2-3H3,(H3,10,11,12,13)
| Molecular Formula | C9H16N2O2 |
| Molecular Weight | 184.2355 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Apronalide is an acyclic analog of barbiturates. It was used under tradename "Sedormid" as a sedative an hypnotic agent. In 1934 it was discovered that the drug causes thrombocytopenic purpura. Apronalide is still marketed in Japan, where it is used in combination with caffeine and ibuprofen for the treatment of headache.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:38:48 GMT 2025
by
admin
on
Mon Mar 31 18:38:48 GMT 2025
|
| Record UNII |
V18J24E25E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QN05CM12
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
||
|
WHO-ATC |
N05CM12
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID00862125
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | |||
|
DB13221
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | |||
|
C005700
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | |||
|
100000084902
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | |||
|
208-443-3
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | |||
|
V18J24E25E
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | |||
|
10715
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | |||
|
SUB21571
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | |||
|
APRONAL
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | |||
|
3678
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | |||
|
m568
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY | Merck Index | ||
|
528-92-7
Created by
admin on Mon Mar 31 18:38:48 GMT 2025 , Edited by admin on Mon Mar 31 18:38:48 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |